Breast cancer drug warning.
D018943:Anthracyclines / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006304:Health Status; D006333:Heart Failure / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D012307:Risk Factors; D000068878:Trastuzumab; D016387:Women's Health
D018943:Anthracyclines; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab